Sufentanil for Anesthesia Induction in Continuous Remifentanil Anesthesia (SAIRA)
Phase IV Study of Postoperative Analgesic Efficacy and Safety of Anesthesia Induction With Single Dose Sufentanil for Open Abdominal Surgery Under Continuous Remifentanil Anesthesia Versus Total Intravenous Remifentanil Anesthesia
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
São Paulo
-
Botucatu, São Paulo, Brazil, 18618970
- Faculdade de Medicina de Botucatu
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Physical status (American Society of Anesthesiologists) 1, 2 or 3
- Age 18 years and older
- Patients selected for open Abdominal surgery under general total intravenous anesthesia
Exclusion Criteria:
- Physical status (American Society of Anesthesiologists) 4
- Patients undergoing other anesthesia technic (subarachnoid, epidural, nerve block, etc)
- History of anaphylactic reaction after use of tramadol, dipyrone, propofol, rocuronium, dexamethasone, sufentanil, remifentanil or morphine
- Chronic uso of drugs that are associated with major increases in the activity of P450 isozymes (Carbamazepine, phenobarbital, rifampin, tobacco, phenytoin, Hypericum perforatum)
- Previous History of Drug addiction
- alcoholism
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: QUADRUPLE
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
EXPERIMENTAL: sufentanil
Anesthetic induction with IV sufentanil at 0.5 mcg.kg-1 and analgesic maintenance with IV remifentanil at 0.1 to 0.3 mcg.kg-1.min-1 on demand target-controlled infusion
|
Sufentanil 0.5 mcg.kg-1 at anesthesia induction (single dose)
Other Names:
|
|
NO_INTERVENTION: remifentanil
Anesthetic induction with target-controlled infusion IV remifentanil at 0.5 mcg.kg-1.min-1 in 5 minutes followed by analgesic maintenance on demand of IV target-controlled infusion remifentanil at 0.1 to 0.3 mcg.kg-1.min-1.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Morphine consumption through patient controlled analgesia pump
Time Frame: 24 hours after surgery
|
24 hours after surgery
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Morphine consumption through patient controlled analgesia pump
Time Frame: 15 minutes after arrival at post-anesthesia care unit
|
15 minutes after arrival at post-anesthesia care unit
|
|
Morphine consumption through patient controlled analgesia pump
Time Frame: 30 minutes after arrival at post-anesthesia care unit
|
30 minutes after arrival at post-anesthesia care unit
|
|
Morphine consumption through patient controlled analgesia pump
Time Frame: 60 minutes after arrival at post-anesthesia care unit
|
60 minutes after arrival at post-anesthesia care unit
|
|
Morphine consumption through patient controlled analgesia pump
Time Frame: 12 hours after surgery
|
12 hours after surgery
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Fernanda B Fukushima, MD PhD, UPECLIN HC FM Botucatu Unesp
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (ACTUAL)
Primary Completion
Study Completion (ACTUAL)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
First Posted
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Pathologic Processes
- Postoperative Complications
- Pain
- Neurologic Manifestations
- Pain, Postoperative
- Physiological Effects of Drugs
- Central Nervous System Depressants
- Peripheral Nervous System Agents
- Analgesics
- Sensory System Agents
- Anesthetics, Intravenous
- Anesthetics, General
- Anesthetics
- Analgesics, Opioid
- Narcotics
- Adjuvants, Anesthesia
- Sufentanil
Other Study ID Numbers
Other Study ID Numbers
- Unesp
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.